SNBIF
Price:
$16.45
Market Cap:
$79.76B
SanBio Company Limited is a biopharmaceutical firm specializing in the development, manufacture, and commercialization of regenerative cell therapies, with a primary focus on disorders of the central nervous system. A significant product in its portfolio is SB623, which has successfully completed Phase 2 clinical trials in both the United States and Japan for the treatment of traumatic brain injury (TBI). The company's research pipeline also explores the potential of SB623 for a variety of other conditions, including ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigmentosa, spinal cord injury, Parkinson's disease, and Alzheimer's disease, among others. Further...[Read more]
Industry
Biotechnology
IPO Date
2015-10-12
Stock Exchange
OTC
Ticker
SNBIF
According to SanBio Company Limited’s latest financial reports and current stock price. The company's current PE Ratio is -49.85. This represents a change of -15.34% compared to the average of -58.88 of the last 4 quarters.
The mean historical PE Ratio of SanBio Company Limited over the last ten years is -33.09. The current -49.85 PE Ratio has changed 14.96% with respect to the historical average. Over the past ten years (40 quarters), SNBIF's PE Ratio was at its highest in in the October 2022 quarter at 32.77. The PE Ratio was at its lowest in in the July 2018 quarter at -180.46.
Average
-33.09
Median
-24.36
Minimum
-119.85
Maximum
-7.75
Discovering the peaks and valleys of SanBio Company Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 158.57%
Maximum Annual PE Ratio = -7.75
Minimum Annual Increase = -81.06%
Minimum Annual PE Ratio = -119.85
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | -35.19 | 104.56% |
| 2025 | -17.20 | 23.01% |
| 2024 | -13.98 | 80.40% |
| 2023 | -7.75 | -35.35% |
| 2022 | -11.99 | -53.92% |
| 2021 | -26.02 | 14.62% |
| 2020 | -22.70 | -81.06% |
| 2019 | -119.85 | 158.57% |
| 2018 | -46.35 | 54.93% |
| 2017 | -29.92 | -33.21% |
The current PE Ratio of SanBio Company Limited (SNBIF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-22.12
5-year avg
-17.22
10-year avg
-33.09
SanBio Company Limited’s PE Ratio is less than Ascletis Pharma Inc. (-22.79), less than Pharming Group N.V. (66.45), less than CStone Pharmaceuticals (-19.08), less than Kuros Biosciences AG (434.27), less than SSY Group Limited (13.29), less than Idorsia Ltd (-6.00), less than PeptiDream Inc. (-34.73), less than Paramount Bed Holdings Co., Ltd. (21.46), less than Towa Pharmaceutical Co., Ltd. (34.60), less than Craneware plc (29.74),
| Company | PE Ratio | Market cap |
|---|---|---|
| -22.79 | $1.42B | |
| 66.45 | $812.19M | |
| -19.08 | $951.23M | |
| 434.27 | $1.03B | |
| 13.29 | $1.19B | |
| -6.00 | $1.91B | |
| -34.73 | $770.95M | |
| 21.46 | $1.15B | |
| 34.60 | $828.51M | |
| 29.74 | $828.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SanBio Company Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SanBio Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is SanBio Company Limited's PE Ratio?
How is the PE Ratio calculated for SanBio Company Limited (SNBIF)?
What is the highest PE Ratio for SanBio Company Limited (SNBIF)?
What is the 3-year average PE Ratio for SanBio Company Limited (SNBIF)?
What is the 5-year average PE Ratio for SanBio Company Limited (SNBIF)?
How does the current PE Ratio for SanBio Company Limited (SNBIF) compare to its historical average?